Table 5 Short-term postoperative outcome, 90-day graft and patient survival of IRI and non-IRI patients
Non-IRI (n = 64) | IRI (n = 46) | p-value | IRI and PCT > 15 mcg/l (n = 27) | p-value (vs. no IRI) | IRI and PCT < 15 mcg/l (n = 19) | p-value (vs. no IRI) | |
|---|---|---|---|---|---|---|---|
Severity of IRI (peak ALT/AST)* | 681 (338–1250) | 4563 (3108–7959) | < 0.001 | 4940 (3324–7607) | < 0.001 | 3721 (2960–9180) | < 0.001 |
Overall major complication** | 34 (53.1%) | 31 (67.4%) | 0.133 | 18 (66.7%) | 0.233 | 13 (68.4%) | 0.237 |
Reoperation | 19 (29.7%) | 25 (54.3%) | 0.009 | 12 (44.4%) | 0.175 | 13 (68.4%) | 0.002 |
Postoperative RRT | 30 (46.9%) | 28 (60.9%) | 0.147 | 17 (63.0%) | 0.161 | 11 (57.9%) | 0.399 |
Arterial complications | 2 (3.1%) | 5 (10.9%) | 0.127 | 2 (7.4%) | 0.579 | 3 (15.8%) | 0.076 |
Hepatic artery thrombosis | 1 (1.6%) | 2 (4.3%) | 0.57 | 1 (3.7%) | 0.508 | 1 (5.3%) | 0.408 |
Biliary complications | 9 (14.1%) | 8 (17.4%) | 0.634 | 3 (11.1%) | 1.0 | 5 (26.3%) | 0.293 |
ICU length of stay (days) | 3 (2–5) | 4 (2–8) | 0.005 | 4 (2–6) | 0.065 | 5 (3–14) | 0.006 |
Hospital length of stay (days) | 17 (13–22) | 17 (13–24) | 0.684 | 16 (13–18) | 0.889 | 21 (11–35) | 0.368 |
90-day outcome | |||||||
90-day graft survival | 60 (93.8%) | 37 (80.4%) | 0.033 | 26 (96.3%) | 1.0 | 11 (57.9%) | 0.001 |
90-day patient survival | 60 (93.8%) | 39 (84.8%) | 0.196 | 26 (96.3%) | 1.0 | 13 (68.4%) | 0.008 |